Remission of Cushing's disease after administration of adrenocorticotropin.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000284:Administration, Oral; D000311:Adrenal Glands / Q000503:physiopathology; D000309:Adrenal Insufficiency / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003480:Cushing Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D013006:Growth Hormone / Q000097:blood; D006400:Hematocrit; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007273:Injections, Intramuscular; D007958:Leukocyte Count; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D012008:Recurrence; D012075:Remission, Spontaneous; D013960:Thyroid Function Tests
D015065:17-Hydroxycorticosteroids; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D006854:Hydrocortisone; D008797:Metyrapone